Omnicell, Inc. (NASDAQ: OMCL) today announced that Spartanburg Regional Healthcare System, an integrated healthcare delivery network in South Carolina and North Carolina, has selected Omnicell® solutions to support pharmacy services and medication management at the flagship research and teaching hospital, Spartanburg Medical Center, as well as the newly acquired Mary Black campuses. Leveraging streamlined workflows and enhanced data insights, Spartanburg Regional is looking to enhance medication management and improve pharmacy performance through Omnicell’s automation and cloud-based predictive intelligence solutions.
Medical errors are reported to be the third leading cause of death in America.1 Spartanburg Regional is the latest health system to partner with Omnicell as the Company launches its vision for Autonomous Pharmacy, a roadmap to develop a zero error, fully automated medication management infrastructure. Leveraging automation, data intelligence, and expert services, the Autonomous Pharmacy vision will empower pharmacists, nurses, clinicians, and pharmacy staff to focus on patient and clinician satisfaction, rather than repetitive, manual tasks.
Spartanburg Regional is planning to launch a centralized distribution center as the main hub for pharmacy supply chain management. Central to operations in the new center will be Omnicell’s XR2 Automated Central Pharmacy System, a robotic system designed to automate critical workflows to maximize inventory control, help improve efficiency and increase medication safety.
The health system will also have the ability to better utilize health data analytics through Omnicell Performance Center™, which combines a cloud-based predictive intelligence platform and expert services that monitor pharmacy operations and recommend opportunities to help improve efficiency, regulatory compliance, and patient outcomes.
“With the rising cost and complexity of managing medications across our health system, we need to better understand patient utilization and the impact on total cost of care,” said Phil Humphrey, system director of Pharmacy. “Through this extended partnership, we will have the knowledge and technology to support our clinical and operational goals.”
In patient care areas, Spartanburg Regional will be implementing Omnicell’s XT Series Automated Dispensing Cabinets to help improve workflow efficiency for both nursing and pharmacy, while helping to increase medication accountability and patient safety.
“By enhancing their existing automation footprint with the most current Omnicell solutions, Spartanburg Regional has the opportunity to leverage technology to free up clinical staff,” said Nhat Ngo, executive vice president, Marketing, Strategy, and Business Development at Omnicell. “Allowing clinicians to practice at the top of their license will ultimately have great impact on patient care and satisfaction.”
About Spartanburg Regional Healthcare System
Spartanburg Regional Healthcare System (SRHS) offers a full spectrum of services through six hospital campuses: Spartanburg Medical Center, Spartanburg Medical Center—Mary Black Campus, Pelham Medical Center, Cherokee Medical Center, Spartanburg Hospital for Restorative Care and Union Medical Center. SRHS also includes Ellen Sagar Nursing Center and Woodruff Manor. SRHS provides unparalleled cancer care through Gibbs Cancer Center & Research Institute, with locations in Spartanburg, Greer, Union and Gaffney. The multidisciplinary Medical Group of the Carolinas has more than 400 physicians across Upstate South Carolina and western North Carolina. SRHS employs more than 9,000 associates and offers outpatient surgery centers and a Level I Trauma Center. In 2017, Spartanburg Medical Center was ranked No. 1 regional hospital in South Carolina and the No. 2 hospital in the state by U.S. News and World Report.
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. The Company’s autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.
Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 5,000 facilities worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.
Omnicell’s innovative medication adherence solutions, used by over 40,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
For more information about Omnicell, Inc. please visit www.omnicell.com.
1 Makary, Martin, MD, MPH. “Medical error—the third leading cause of death in the US.” BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2139 (Published 03 May 2016)
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by Business Wire and are immediately thereafter posted on the company’s external website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.